Nationwide Fund Advisors - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 82 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2014. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2017$3,053,000
-18.1%
57,314
-4.5%
0.01%
-20.0%
Q2 2017$3,728,000
+13.8%
60,023
+24.2%
0.02%
+15.4%
Q1 2017$3,276,000
-5.6%
48,338
-2.1%
0.01%
-7.1%
Q4 2016$3,472,000
-0.5%
49,387
+0.4%
0.01%
-6.7%
Q3 2016$3,490,000
-8.1%
49,200
-36.6%
0.02%
-6.2%
Q2 2016$3,796,000
-31.7%
77,610
-11.2%
0.02%
-33.3%
Q1 2016$5,555,000
-39.1%
87,371
+7.5%
0.02%
-38.5%
Q4 2015$9,121,000
+13.5%
81,305
-2.5%
0.04%
+8.3%
Q3 2015$8,033,000
+5.9%
83,410
+12.5%
0.04%
+16.1%
Q2 2015$7,589,000
+110.6%
74,119
+27.7%
0.03%
+106.7%
Q1 2015$3,604,000
+55.9%
58,050
+10.2%
0.02%
+50.0%
Q4 2014$2,312,000
-12.3%
52,699
+13.2%
0.01%
-9.1%
Q3 2014$2,635,000
+234.4%
46,547
+165.1%
0.01%
+266.7%
Q2 2014$788,000
+59.2%
17,555
+73.2%
0.00%
+50.0%
Q1 2014$495,00010,1330.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2014
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders